Cinven set to back-levered Sebia deal

© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cinven set to back-levered Sebia deal

Leveraged loan houses are turning their attention to the Eu800m buyout of Sebia. Cinven bought the French medical diagnostics group on Monday, after having only made a bid on Thursday. Such was its eagerness to get hold of the company that it funded the whole takeover with equity. It is now trying to raise debt. Loans bankers expect a deal of about Eu400m to emerge. Read more on Friday.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request demo or Login
  • 4,000 annual insights
  • 700+ notes and long-form analyses
  • 4 capital markets databases
  • Daily newsletters across markets and asset classes
  • 2 weekly podcasts
Gift this article